Immediate Impact
5 by Nobel laureates 2 from Science/Nature 60 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Works of Raquel Bratos being referenced
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
2020 Standout
Mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients (pts) with platinum-resistant ovarian cancer: Final findings from the FORWARD II study.
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Raquel Bratos | 105 | 314 | 216 | 211 | 13 | 581 | |
| Steven DeCesare | 140 | 242 | 234 | 251 | 13 | 679 | |
| Andreas duBois | 101 | 288 | 396 | 124 | 15 | 701 | |
| Albert Steren | 89 | 254 | 330 | 251 | 21 | 708 | |
| Joyce Varughese | 77 | 320 | 115 | 116 | 21 | 610 | |
| Elisabeth Janschek | 114 | 309 | 171 | 154 | 16 | 637 | |
| Melina Shoni | 151 | 124 | 181 | 217 | 22 | 602 | |
| Richard A. Boothby | 67 | 315 | 283 | 102 | 7 | 585 | |
| A. De Jesus Acosta | 118 | 299 | 103 | 150 | 9 | 513 | |
| Sarper Toker | 106 | 326 | 102 | 273 | 10 | 581 | |
| M. Valeria Cáceres | 110 | 350 | 109 | 289 | 11 | 613 |
All Works
Loading papers...